… CpG ODN were effective as vaccine adjuvants in multiple species. CpG ODN adjuvanted
AVA induced a rapid and protective toxin-neutralizing Ab response in guinea pigs [113]. Calves …

… vaccine adjuvants, including optimization of adjuvant formulations, design of new adjuvants
and … As efficient vaccine adjuvants, CpG ODN can promote the immunostimulatory effect of …

… a DNA vaccine based on a recombinant pre-membrane (prM) and envelope (E) protein,
using CpG oligodeoxynucleotide (ODN) as an adjuvanted, … , a DNA vaccine pVAX1-prM/E-CpG, …

… one CpG per OVA. Our findings suggest that tuning molecular composition of antigen-CpG …
molecular tuning and may be useful for continued development of antigen-CpG vaccines. …

… While this study is focused to evaluate CaP-CpG nanoparticles as potential adjuvants for
enhanced vaccine delivery applications, we envision that our results will also enable better …

… It has been shown in a murine model that CpG-B ODN as an adjuvant causes
considerable and long-lasting antibody production, better than alum-adjuvated or non-adjuvated …

… Expert opinion: HEPLISAV-B, a CpG adjuvant mixed with HBsAg, is more efficacious and
produced earlier seroprotection compared to existing vaccines, with a favorable safety profile. …

… CpG reduce antigen dose in mice [16] and high dosage may increase product-cost and
workload, we wonder whether CpG ODNs could be used as a safer adjuvant … class B CpG ODNs …

… DNA nanodevice vaccine generated by precisely assembling two types of molecular adjuvants
… CpG motifs (TLR9 agonist) as adjuvant 2 (Supplementary Fig. 4). The sticky ends of the …

… On the basis of this technical theory, studies have proposed an innovative research idea,
using CpG DNA not only as the immune adjuvant, but also as the carrier material of …